Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

At a crossroad: cell therapy for cardiac repair.

Deutsch MA, Sturzu A, Wu SM.

Circ Res. 2013 Mar 15;112(6):884-90. doi: 10.1161/CIRCRESAHA.112.275974. No abstract available.

2.

Current outlook of cardiac stem cell therapy towards a clinical application.

Takashima S, Tempel D, Duckers HJ.

Heart. 2013 Dec;99(23):1772-84. doi: 10.1136/heartjnl-2012-303308. Epub 2013 Mar 22. No abstract available.

PMID:
23525708
3.

Injection of Sca-1+/CD45+/CD31+ mouse bone mesenchymal stromal-like cells improves cardiac function in a mouse myocardial infarct model.

He J, Teng X, Yu Y, Huang H, Ye W, Ding Y, Shen Z.

Differentiation. 2013 Jul-Sep;86(1-2):57-64. doi: 10.1016/j.diff.2013.07.002. Epub 2013 Aug 25.

PMID:
23974360
4.

Stemming electrical outage in myocardial infarction.

Akeju O, Alston TA.

Crit Care Med. 2011 May;39(5):1222-3. doi: 10.1097/CCM.0b013e31820a838a. No abstract available.

PMID:
21610588
5.

[Cardiac cell therapy: the puzzle is waiting to be solved].

Canepa M, Coviello D, Chiarella F.

G Ital Cardiol (Rome). 2006 Apr;7(4):252-65. Review. Italian.

PMID:
16700408
6.

Stem cell therapy in heart diseases: a review of selected new perspectives, practical considerations and clinical applications.

Abdelwahid E, Siminiak T, Guarita-Souza LC, Teixeira de Carvalho KA, Gallo P, Shim W, Condorelli G.

Curr Cardiol Rev. 2011 Aug;7(3):201-12. Review.

7.

Pluripotent stem cell-engineered cell sheets reassembled with defined cardiovascular populations ameliorate reduction in infarct heart function through cardiomyocyte-mediated neovascularization.

Masumoto H, Matsuo T, Yamamizu K, Uosaki H, Narazaki G, Katayama S, Marui A, Shimizu T, Ikeda T, Okano T, Sakata R, Yamashita JK.

Stem Cells. 2012 Jun;30(6):1196-205. doi: 10.1002/stem.1089.

8.

[Progress of studies on mesenchymal stem cells and myocardial regeneration].

Xia SL.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2004 Nov;33(6):556-60. Review. Chinese. No abstract available.

PMID:
15586419
9.

Dose-dependent systolic contribution of differentiated stem cells in post-infarct ventricular function.

Shim WS, Tan G, Gu Y, Qian L, Li S, Chung YY, Lim SY, Sim E, Chuah SC, Wong P.

J Heart Lung Transplant. 2010 Dec;29(12):1415-26. doi: 10.1016/j.healun.2010.06.009. Epub 2010 Aug 4.

PMID:
20688539
10.

Video-assisted thoracoscopic transplantation of myoblasts into the heart.

Carraro U.

Ann Thorac Surg. 2004 Jul;78(1):14-6. No abstract available.

PMID:
15223392
11.

Cardiac repair by stem cells.

Sánchez A, García-Sancho J.

Cell Death Differ. 2007 Jul;14(7):1258-61. Epub 2007 Apr 13. Review. No abstract available.

12.

Sox2 transduction enhances cardiovascular repair capacity of blood-derived mesoangioblasts.

Koyanagi M, Iwasaki M, Rupp S, Tedesco FS, Yoon CH, Boeckel JN, Trauth J, Schütz C, Ohtani K, Goetz R, Iekushi K, Bushoven P, Momma S, Mummery C, Passier R, Henschler R, Akintuerk H, Schranz D, Urbich C, Galvez BG, Cossu G, Zeiher AM, Dimmeler S.

Circ Res. 2010 Apr 16;106(7):1290-302. doi: 10.1161/CIRCRESAHA.109.206045. Epub 2010 Feb 25.

13.

[Stem cell perspectives in myocardial infarctions].

Aceves JL, Archundia A, Díaz G, Páez A, Masso F, Alvarado M, López M, Aceves R, Ixcamparij C, Puente A, Vilchis R, Montaño LF.

Rev Invest Clin. 2005 Mar-Apr;57(2):156-62. Review. Spanish.

PMID:
16524054
14.

Boot camp for mesenchymal stem cells.

Marbán E, Malliaras K.

J Am Coll Cardiol. 2010 Aug 24;56(9):735-7. doi: 10.1016/j.jacc.2010.02.064. No abstract available.

15.

Overexpression of TNNI3K, a cardiac-specific MAP kinase, promotes P19CL6-derived cardiac myogenesis and prevents myocardial infarction-induced injury.

Lai ZF, Chen YZ, Feng LP, Meng XM, Ding JF, Wang LY, Ye J, Li P, Cheng XS, Kitamoto Y, Monzen K, Komuro I, Sakaguchi N, Kim-Mitsuyama S.

Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H708-16. doi: 10.1152/ajpheart.00252.2008. Epub 2008 Jun 13. Erratum in: Am J Physiol Heart Circ Physiol. 2008 Oct;295(4):H815.

16.

Stem cell therapy for the infarcted heart ("cellular cardiomyoplasty").

Dengler TJ, Katus HA.

Herz. 2002 Nov;27(7):598-610. Review.

PMID:
12439632
17.

Stem cells in cardiac repair.

Henning RJ.

Future Cardiol. 2011 Jan;7(1):99-117. doi: 10.2217/fca.10.109. Review.

PMID:
21174514
18.

Delayed enrichment for c-kit and inducing cardiac differentiation attenuated protective effects of BMSCs' transplantation in pig model of acute myocardial ischemia.

Zhang GW, Gu TX, Guan XY, Sun XJ, Jiang DQ, Tang R, Qi X, Li XY.

Cardiovasc Ther. 2015 Aug;33(4):184-92. doi: 10.1111/1755-5922.12131.

PMID:
25959676
19.

Reprogramming cells for transplantation.

Leor J, Battler A, Kloner RA, Etzion S.

Heart Fail Rev. 2003 Jul;8(3):285-92. Review.

PMID:
12878838
20.

Induced pluripotent stem (iPS) cells repair and regenerate infarcted myocardium.

Singla DK, Long X, Glass C, Singla RD, Yan B.

Mol Pharm. 2011 Oct 3;8(5):1573-81. doi: 10.1021/mp2001704. Epub 2011 May 24.

PMID:
21542647

Supplemental Content

Support Center